Literature DB >> 3029765

Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro.

L Yang, M S Wold, J J Li, T J Kelly, L F Liu.   

Abstract

We examined the roles of DNA topoisomerases in the replication of simian virus 40 (SV40) DNA in a cell-free system composed of an extract from HeLa cells supplemented with purified SV40 tumor antigen. When the activities of both topoisomerase I (EC 5.99.1.2) and topoisomerase II (EC 5.99.1.3) in the extract were blocked with specific inhibitors or antibodies, DNA synthesis was decreased by a factor of 15-20. Addition of purified HeLa DNA topoisomerase II to extracts immunologically depleted of both topoisomerases completely restored replication, and the replication products consisted largely of monomeric daughter molecules. Addition of purified HeLa DNA topoisomerase I to depleted extracts restored DNA synthesis, but the primary products were multiply intertwined, catenated daughter molecules. We conclude that DNA topoisomerases have at least two roles in the replication of SV40 DNA. Either topoisomerase I or topoisomerase II is sufficient to provide the unlinking activity necessary for fork propagation during SV40 DNA replication. However, topoisomerase II is uniquely required for the segregation of newly synthesized daughter molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029765      PMCID: PMC304337          DOI: 10.1073/pnas.84.4.950

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerases.

Authors:  L F Liu; J L Davis; R Calendar
Journal:  Nucleic Acids Res       Date:  1981-08-25       Impact factor: 16.971

Review 2.  DNA topoisomerases.

Authors:  M Gellert
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

3.  Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei.

Authors:  L F Liu; K G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

4.  A homogeneous type II DNA topoisomerase from HeLa cell nuclei.

Authors:  K G Miller; L F Liu; P T Englund
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

Review 5.  DNA topoisomerases--enzymes that catalyse the breaking and rejoining of DNA.

Authors:  L F Liu
Journal:  CRC Crit Rev Biochem       Date:  1983

6.  Eukaryotic DNA replication: viral and plasmid model systems.

Authors:  M D Challberg; T J Kelly
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

7.  Purification of simian virus 40 large T antigen by immunoaffinity chromatography.

Authors:  R A Dixon; D Nathans
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.

Authors:  S DiNardo; K Voelkel; R Sternglanz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  Arrest of segregation leads to accumulation of highly intertwined catenated dimers: dissection of the final stages of SV40 DNA replication.

Authors:  O Sundin; A Varshavsky
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

10.  Mitotic spindle pulls but fails to separate chromosomes in type II DNA topoisomerase mutants: uncoordinated mitosis.

Authors:  T Uemura; M Tanagida
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more
  102 in total

1.  Topoisomerase II can unlink replicating DNA by precatenane removal.

Authors:  I Lucas; T Germe; M Chevrier-Miller; O Hyrien
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitro.

Authors:  K Søe; G Dianov; H P Nasheuer; V A Bohr; F Grosse; T Stevnsner
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

3.  Simian virus 40 DNA replication in vitro: identification of multiple stages of initiation.

Authors:  T Tsurimoto; M P Fairman; B Stillman
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

4.  Human topoisomerase I cleavage complexes are repaired by a p53-stimulated recombination-like reaction in vitro.

Authors:  Holger Stephan; Frank Grosse; Kent Søe
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

5.  Nonspecific DNA binding activity of simian virus 40 large T antigen: evidence for the cooperation of two regions for full activity.

Authors:  H J Lin; R H Upson; D T Simmons
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

6.  Topoisomerase I is preferentially associated with normal SV40 replicative intermediates, but is associated with both replicating and nonreplicating SV40 DNAs which are deficient in histones.

Authors:  J J Champoux
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

7.  Structure of the ColE1 DNA molecule before segregation to daughter molecules.

Authors:  S Nakasu; J Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Dideoxynucleoside triphosphates inhibit a late stage of SV40 DNA replication in vitro.

Authors:  P Zahradka
Journal:  Mol Cell Biochem       Date:  1992-03-04       Impact factor: 3.396

9.  Structural basis for the interaction of a hexameric replicative helicase with the regulatory subunit of human DNA polymerase α-primase.

Authors:  Bo Zhou; Diana R Arnett; Xian Yu; Aaron Brewster; Gregory A Sowd; Charlies L Xie; Stefan Vila; Dahai Gai; Ellen Fanning; Xiaojiang S Chen
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

10.  Multiple functions of human single-stranded-DNA binding protein in simian virus 40 DNA replication: single-strand stabilization and stimulation of DNA polymerases alpha and delta.

Authors:  M K Kenny; S H Lee; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.